[{"address1": "22 Einstein Street", "address2": "Floor 4", "city": "Ness Ziona", "zip": "7414003", "country": "Israel", "phone": "972 7 2394 2377", "website": "https://www.biomx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "BiomX Inc., a clinical-stage biopharmaceutical company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria associated with chronic disease. It is developing BX211, a phage therapy, which is in phase 2 clinical study for the treatment of diabetic foot osteomyelitis. The company's product pipeline also includes BX004, a phage therapy for cystic fibrosis patients with chronic pulmonary infections caused by Pseudomonas aeruginosa that is in Phase 1b/2a clinical trials. BiomX Inc. was founded in 2015 and is headquartered in Ness Ziona, Israel.", "fullTimeEmployees": 58, "companyOfficers": [{"maxAge": 1, "name": "Mr. Jonathan Eitan Solomon MBA", "age": 46, "title": "CEO & Director", "yearBorn": 1977, "fiscalYear": 2023, "totalPay": 714367, "exercisedValue": 0, "unexercisedValue": 3978}, {"maxAge": 1, "name": "Ms. Marina  Wolfson CPA", "age": 39, "title": "CFO & Secretary", "yearBorn": 1984, "fiscalYear": 2023, "totalPay": 337514, "exercisedValue": 0, "unexercisedValue": 153}, {"maxAge": 1, "name": "Dr. Merav  Bassan Ph.D.", "age": 57, "title": "Chief Development Officer", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 437713, "exercisedValue": 0, "unexercisedValue": 1149}, {"maxAge": 1, "name": "Prof. Rotem  Sorek Ph.D.", "title": "Scientific Founder", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Eran  Elinav M.D., Ph.D.", "title": "Scientific Founder", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Timothy K. Lu M.D., Ph.D.", "age": 42, "title": "Scientific Founder", "yearBorn": 1981, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Inbal  Benjamini-Elran", "title": "C.H.R.O", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.76, "open": 0.79, "dayLow": 0.744, "dayHigh": 0.79, "regularMarketPreviousClose": 0.76, "regularMarketOpen": 0.79, "regularMarketDayLow": 0.744, "regularMarketDayHigh": 0.79, "beta": 1.322, "volume": 31845, "regularMarketVolume": 31845, "averageVolume": 114101, "averageVolume10days": 72820, "averageDailyVolume10Day": 72820, "bid": 0.7403, "ask": 0.8374, "bidSize": 800, "askSize": 800, "marketCap": 13945087, "fiftyTwoWeekLow": 0.48, "fiftyTwoWeekHigh": 8.55, "fiftyDayAverage": 0.67262, "twoHundredDayAverage": 1.985305, "currency": "USD", "enterpriseValue": 24126884, "forwardPE": -0.30444443, "floatShares": 13547334, "sharesOutstanding": 18176600, "sharesShort": 23032, "sharesShortPriorMonth": 37156, "sharesShortPreviousMonthDate": 1727654400, "dateShortInterest": 1730332800, "sharesPercentSharesOut": 0.0013, "heldPercentInsiders": 0.11675999, "heldPercentInstitutions": 0.5231, "shortRatio": 0.74, "shortPercentOfFloat": 0.0015, "impliedSharesOutstanding": 18176600, "bookValue": 0.67, "priceToBook": 1.1450746, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -26253000, "trailingEps": -3.26, "lastSplitFactor": "1:10", "lastSplitDate": 1724630400, "enterpriseToEbitda": -0.871, "52WeekChange": -0.66222227, "SandP52WeekChange": 0.22408533, "exchange": "ASE", "quoteType": "EQUITY", "symbol": "PHGE", "underlyingSymbol": "PHGE", "shortName": "BiomX Inc.", "longName": "BiomX Inc.", "firstTradeDateEpochUtc": 1552483800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "79f496b8-a482-326c-9356-662c9a6d1300", "messageBoardId": "finmb_430935769", "gmtOffSetMilliseconds": -18000000, "currentPrice": 0.7672, "targetHighPrice": 12.0, "targetLowPrice": 2.0, "targetMeanPrice": 7.0, "targetMedianPrice": 7.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 2, "totalCash": 31611000, "totalCashPerShare": 1.766, "ebitda": -27712000, "totalDebt": 9896000, "quickRatio": 4.423, "currentRatio": 4.802, "debtToEquity": 36.084, "returnOnAssets": -0.32654998, "returnOnEquity": -1.21289, "freeCashflow": -17369000, "operatingCashflow": -34757000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2025-01-18"}]